RMD vs TENX · P/E 29, rev $5.65B vs P/E 3.4, $24.1M cap
ResMed Inc (RMD) versus Tenax Therapeutics Inc (TENX) — a side-by-side from cached financials, not a winner call.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Tenax Therapeutics Inc (TENX) is a biotechnology company listed on US.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Latest reported TENX revenue for 2026-06-30 was $0. Net income was -$33.5M. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
RMD currently screens at market cap $37.68B and trailing P/E 28.8. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
Not investment advice. Open the RMD and TENX stock pages for the full models.
Not investment advice.